Literature DB >> 18806997

[Effective pain relief facilitates exercise therapy : Results of a multicenter study with controlled-release oxycodone in patients with movement pain].

W Teske1, A Anastasiadis, J Krämer, T Theodoridis.   

Abstract

BACKGROUND: The efficacy and tolerability of oral controlled-release oxycodone in the therapy of musculoskeletal pain were analyzed in this observational study. PATIENTS AND METHODS: A total of 843 patients with severe to most severe pain in the musculoskeletal system were treated with controlled-released oxycodone for 4 weeks or up to a maximum of 6 months. Severity of pain, impairment in quality of life, and mobility associated with the pain were assessed before and during therapy with controlled-release oxycodone by a numerical rating scale (NRS 0-10).
RESULTS: Pain intensity fell by an average of 65% within the first 4 weeks. Physical therapy was practicable in many patients only after implementation of a therapy regime with controlled-release oxycodone. Quality of life improved significantly under therapy with oxycodone, and the impairment of different aspects of life decreased by 50%.
CONCLUSION: The therapy of pain of the musculoskeletal system with controlled-release oxycodone is efficient. An effective pain relief makes physical therapy practicable, reduces the impairment in different parts of life, and increases quality of life.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806997     DOI: 10.1007/s00132-008-1344-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  26 in total

1.  [Rethinking in pain therapy. Thus you grab backache in its roots].

Authors:  Thomas Meissner
Journal:  MMW Fortschr Med       Date:  2007-08-16

2.  Pharmacokinetics and pharmacodynamics of controlled-release opioids.

Authors:  R F Kaiko
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

3.  Transdermal fentanyl as treatment for chronic low back pain.

Authors:  R K Simpson; E A Edmondson; C F Constant; C Collier
Journal:  J Pain Symptom Manage       Date:  1997-10       Impact factor: 3.612

4.  Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial.

Authors:  Joseph A Markenson; Joseph Croft; P G Zhang; Patricia Richards
Journal:  Clin J Pain       Date:  2005 Nov-Dec       Impact factor: 3.442

5.  Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.

Authors:  M E Hale; R Fleischmann; R Salzman; J Wild; T Iwan; R E Swanton; R F Kaiko; P G Lacouture
Journal:  Clin J Pain       Date:  1999-09       Impact factor: 3.442

6.  Opioid use by patients in an orthopedics spine clinic.

Authors:  Maren L Mahowald; Jasvinder A Singh; Peter Majeski
Journal:  Arthritis Rheum       Date:  2005-01

Review 7.  [Chronic pain. Epidemiology and management in Germany].

Authors:  M Zimmermann
Journal:  Orthopade       Date:  2004-05       Impact factor: 1.087

8.  Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain.

Authors:  Arnold R Gammaitoni; Bradley S Galer; Peter Lacouture; John Domingos; Thomas Schlagheck
Journal:  Pain Med       Date:  2003-03       Impact factor: 3.750

9.  Opioid therapy for chronic noncancer back pain. A randomized prospective study.

Authors:  R N Jamison; S A Raymond; E A Slawsby; S S Nedeljkovic; N P Katz
Journal:  Spine (Phila Pa 1976)       Date:  1998-12-01       Impact factor: 3.468

10.  Randomised trial of oral morphine for chronic non-cancer pain.

Authors:  D E Moulin; A Iezzi; R Amireh; W K Sharpe; D Boyd; H Merskey
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.